Preclinical Quality and GLP QA Consultant (Contract, Onsite Houston)
"Radiomedix, Inc."
·Today
- Location
- Houston, TX
- Workplace
- Onsite
- Type
- Contract
- Education
- PhD
- Closing date
- Today
- Source
- ApplyToJob
Description
ABOUT RADIOMEDIX
RadioMedix is a Houston-based radiopharmaceutical company developing targeted diagnostic and therapeutic agents, including alpha-emitting (lead-212) therapies. Our preclinical group runs a growing portfolio of in vitro and in vivo studies in efficacy, biodistribution, dosimetry, and safety, supporting multiple programs as they advance toward IND submissions.
ABOUT THE ROLE
As our pipeline moves closer to the clinic, we are investing in our preclinical quality framework to support the next stage of growth. We are looking for an experienced GLP quality professional to join our team onsite and partner with our PhD-level scientists to strengthen and scale how we plan, document and report studies.
You will help shape our standards for GLP and GLP-like (non-GLP, IND-supporting) studies, serve as our GLP Quality Assurance lead during the engagement, and share your expertise with a highly capable scientific team.
This is a great fit for someone who enjoys building scalable systems in a collaborative, science-driven environment and who brings a practical, mentoring approach.
Strengthen and scale our quality framework
• Review our current preclinical processes and recommend improvements aligned with GLP (21 CFR Part 58) and FDA expectations for IND nonclinical data
• Develop and refine SOPs covering study initiation and protocol approval, amendments and deviations, Good Documentation Practices, test article documentation, data management and archiving, final reports and QC review, CRO oversight, and study tiering
• Develop templates for protocols, amendments, deviations, final reports and QC checklists
• Partner with our R&D Project Manager on study numbering and registry tools
Define GLP and GLP-like standards
• Formalize standards for GLP studies and GLP-like studies, with clear criteria for assigning each study a tier at the planning stage
• GLP: pivotal toxicology, safety pharmacology within those studies, and supporting dose formulation analysis, typically conducted with CRO partners
• GLP-like: IND-supporting efficacy, biodistribution, dosimetry, in vivo stability and pilot dose-range studies conducted in-house
• Align ongoing studies to the tiering framework and create a GLP-like checklist for study leads
• Define radiopharmaceutical-specific records such as radioactivity measurements, decay correction, dose calibrator checks and isotope lot traceability
Lead GLP Quality Assurance
• Maintain the GLP master schedule and review GLP protocols for compliance
• Inspect critical study phases, audit final reports against raw data and issue QA statements
• Audit CRO partners conducting our GLP studies, acting as sponsor QA
• Perform or oversee QC review of GLP-like study reports
• Track findings and corrective actions to closure
Share expertise and build capability
• Lead training on Good Documentation Practices, GLP principles and updated procedures
• Mentor 2 to 3 scientists as they take on Study Lead and Study Director roles
• Advise study leads as they apply the updated framework to new protocols and reports
• Participate in a biweekly nonclinical study review meeting
In keeping with GLP best practice, this role maintains QA independence and does not serve as Study Director or Study Lead on studies it audits.
Required
• PhD in a life science (biology, pharmacology, toxicology, chemistry or a related field)
• 8+ years in preclinical or nonclinical drug development, including 5+ years as a GLP QA auditor (issuing QA statements and auditing CROs)
• In-depth knowledge of 21 CFR Part 58 and IND nonclinical requirements (21 CFR 312.23(a)(8))
• Hands-on experience writing SOPs and templates and building study registries or quality systems
• Experience overseeing GLP studies at CROs as the sponsor's representative and defining standards for non-GLP studies
• Strong mentoring and communication skills, with experience supporting scientific teams through process improvements
• Practical judgment: able to tailor procedures to a growing, innovative company
Preferred
• Experience with radiopharmaceuticals or radiolabeled compounds, ideally therapeutic or alpha-emitting
• Familiarity with FDA guidance on nonclinical studies for oncology therapeutic radiopharmaceuticals and ICH S9
• Experience with in vivo oncology efficacy, biodistribution or dosimetry studies
• Experience supporting IND nonclinical sections (eCTD Modules 2.4, 2.6 and 4)
• Experience with electronic lab notebooks or data management systems
• Prior work in a radiation-controlled laboratory
WORKING ARRANGEMENT
• Onsite in Houston every weekday, about 4 hours per day (20 hours per week)
• Limited remote work for document drafting is acceptable
• Completion of radiation safety and site onboarding is required before lab access
• Confidentiality and IP agreements are required
RadioMedix is an equal opportunity employer. We consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status or any other legally protected status.